Aktuelle Urol 2016; 47(04): 300-304
DOI: 10.1055/s-0042-104804
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Welchen Einfluss haben Symptome des unteren Harntraktes auf die weibliche Sexualität?

How Does Lower Urinary Tract Dysfunction Affekt Female Sexuality?
R. Anding
1   Neuro-Urologie, Urologische Universitätsklinik, Rheinische Friedrich-Wilhelms-Universität Bonn und Neurologisches Rehabilitationszentrum Godeshöhe
,
R. Kirschner-Hermanns
1   Neuro-Urologie, Urologische Universitätsklinik, Rheinische Friedrich-Wilhelms-Universität Bonn und Neurologisches Rehabilitationszentrum Godeshöhe
,
A. Rantell
2   Urogynaecology, King’s College Hospital, London, UK
,
A. Wiedemann
3   Urologische Klinik, Ev. Krankenhaus Witten gGmbH und Lehrstuhl für Geriatrie, Universität Witten/Herdecke
› Author Affiliations
Further Information

Publication History

Publication Date:
21 June 2016 (online)

Zusammenfassung

Viele Frauen leiden mit zunehmendem Alter sowohl unter Symptomen des unteren Harntraktes, als auch unter Sexualstörungen. Große epidemiologische Studien belegen einheitlich Zusammenhänge zwischen der Überaktiven Blase und einer sexuellen Dysfunktion. Insbesondere Frauen mit einer urodynamisch bewiesenen Detrusorhyperaktivität und einer damit verbundenen Harninkontinenz leiden unter einer sexuellen Dysfunktion. Eine erfolgreiche Therapie einer Belastungsinkontinenz geht mit einer Verbesserung der sexuellen Gesundheit einher.

Abstract

With increasing age many women suffer from lower urinary tract dysfunction (LUTD) and female sexual dysfunction. An increasing body of evidence supports an association between the 2 conditions. Especially women with urodynamically proved detrusor hyperactivity suffer from sexual dysfunction and there is some evidence that in patients with stress incontinence sexual health improves after successful surgery.

Editorial Comment

 
  • Literatur

  • 1 Gordon D, Groutz A, Sinai T et al. Sexual function in women attending a urogynecology clinic. Int Urogynecol J Pelvic Floor Dysfunct 1999; 10: 325-328
  • 2 Yip SK, Chan A, Pang S et al. The impact of urodynamic stress incontinence and detrusor overactivity on marital relationship and sexual function. Am J Obstet Gynecol 2003; 188: 1244-1248
  • 3 Salonia A, Zanni G, Nappi RE et al. Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross-sectional study. Eur Urol 2004; 45: 642-648 discussion 648
  • 4 Handa VL, Harvey L, Cundiff GW et al. Sexual function among women with urinary incontinence and pelvic organ prolapse. Am J Obstet Gynecol 2004; 191: 751-756
  • 5 Coyne KS, Margolis MK, Jumadilova Z et al Overactive bladder and women’s sexual health: what is the impact?. J Sex Med 2007; 4: 656-666
  • 6 Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol 2002; 187: 116-126
  • 7 Abrams P, Cardozo L, Khoury S, Wein A. (eds.) Incontinence. 4th (ed.) Health Publications Ltd.; 2013
  • 8 Coyne KS, Sexton CC, Irwin D et al. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU International 2008; 101: 1388-1395
  • 9 Mercer C, Tanton C, Prah P et al. Changes in sexual attitudes and lifestyles in Britain through the life course and over time: findings from the National Surveys of Sexual Attitudes and Lifestyles (NATSAL). The Lancet 2013; 382: 1781-1794
  • 10 World Health Organisation. Defining sexual health Report of a technical consultation on sexual health. Geneva: WHO; 2006
  • 11 World Health Organisation. International statistical classification of diseases and related health problems (ICD-10). Geneva: WHO; 1992
  • 12 Basson R, Berman J, Burnett A et al. Report of the International Consensus development conference on female sexual dysfunction. J of Urol 2000; 163: 888-893
  • 13 Graham CA. The DSM diagnostic criteria for female orgasmic disorder. Arch Sex Behav 2010; 39: 256-270
  • 14 Richters J, Grulich AE, Visser RO et al. Sex in Australia: Sexual difficulties in a representative sample of adults. Australian and New Zealand journal of public health 2003; 27: 164-170
  • 15 Giraldi A, Salonia A, Levin R et al. Physiology of Women’s Sexual Function. In Montorsi F, Basson R, Adaikan G, Becher E, Clayton A, Giuliano F, Khoury S, Sharlip I. Sexual Medicine. Paris: Health Publication Ltd; 2010: 1067-1122
  • 16 Salonia A, Giraldi A, Chivers ML et al. Physiology of women's sexual function: basic knowledge and new findings. J Sex Med 2010; 7: 2637-2660
  • 17 Shaw C. A systematic review of the literature on the prevalence of sexual impairment in women with urinary incontinence and the prevalence of urinary leakage during sexual activity. Eur Urol 2002; 42: 432-440
  • 18 Cohen BL, Barboglio P, Gousse A. The impact of lower urinary tract symptoms and urinary incontinence on female sexual dysfunction using a validated instrument. J Sex Med 2008; 5: 1418-1423
  • 19 Su CC, Sun BY, Jiann BP. Association of urinary incontinence and sexual function in women. Int J Urol 2015; 22: 109-113
  • 20 Coyne KS, Sexton CC, Thompson C et al. The impact of OAB on sexual health in men and women: results from EpiLUTS. J Sex Med 2011; 8: 1603-1615
  • 21 Sand PK, Goldberg RP, Dmochowski RR et al. The impact of the overactive bladder syndrome on sexual function: a preliminary report from the Multicenter Assessment of Transdermal Therapy in Overactive Bladder with Oxybutynin trial. Am J Obstet Gynecol 2006; 195: 1730-1735
  • 22 Rogers R, Bachmann G, Jumadilova Z et al. Efficacy of tolterodine on overactive bladder symptoms and sexual and emotional quality of life in sexually active women. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19: 1551-1557
  • 23 Hajebrahimi S, Azaripour A, Sadeghi-Bazargani H. Tolterodine immediate release improves sexual function in women with overactive bladder. J Sex Med 2008; 5: 2880-2885
  • 24 Rogers RG, Omotosho T, Bachmann G et al. Continued symptom improvement in sexually active women with overactive bladder and urgency urinary incontinence treated with tolterodine ER for 6 months. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20: 381-385
  • 25 Simon JA, Nappi RE, Kingsberg SA et al. Clarifying Vaginal Atrophy's Impact on Sex and Relationships (CLOSER) survey: emotional and physical impact of vaginal discomfort on North American postmenopausal women and their partners. Menopause 2014; 21: 137-142
  • 26 Cody JD, Jacobs ML, Richardson K et al. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev 2012; 10 CD001405
  • 27 Committee on Gynecologic Practice (The American College of Obstetricians and Gynecologists). Committee Opinion No. 659. The Use of Vaginal Estrogen in Women With a History of Estrogen-Dependent Breast Cancer. Obstet Gynecol 2016; 127: e93-e96
  • 28 Fan Y, Huang Z, Yu D. Incontinence-specific quality of life measures used in trials of sling procedures for female stress urinary incontinence: a meta-analysis. Int Urol Nephrol 2015; 47: 1277-1295
  • 29 Banakhar M, Gazwani Y, Kelini ME et al. Effect of sacral neuromodulation on female sexual function and quality of life: Are they correlated?. Can Urol Assoc J 2014; 8: E762-E767
  • 30 Gill BC, Swartz MA, Firoozi F et al. Improved sexual and urinary function in women with sacral nerve stimulation. Neuromodulation 2011; 14: 436-443 discussion 443
  • 31 Pauls RN, Marinkovic SP, Silva WA et al. Effects of sacral neuromodulation on female sexual function. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18: 391-395
  • 32 Signorello D, Seitz CC, Berner L et al. Impact of sacral neuromodulation on female sexual function and his correlation with clinical outcome and quality of life indexes: a monocentric experience. J Sex Med 2011; 8: 1147-1155
  • 33 Parnell BA, Howard Jr JF, Geller EJ. The effect of sacral neuromodulation on pudendal nerve function and female sexual function. Neurourol Urodyn 2015; 34: 456-460
  • 34 Meloy TS, Southern JP. Neurally augmented sexual function in human females: a preliminary investigation. Neuromodulation 2006; 9: 34-40
  • 35 van Voskuilen AC, Oerlemans DJ, Gielen N et al. Sexual response in patients treated with sacral neuromodulation for lower urinary tract symptoms or fecal incontinence. Urol Int 2012; 88: 423-430
  • 36 Kohler TS, McVary KT. The relationship between erectile dysfunction and lower urinary tract symptoms and the role of phosphodiesterase type 5 inhibitors. Eur Urol 2009; 55: 38-48
  • 37 Lowenstein L, Gamble T, Sanses TV et al. Sexual function is related to body image perception in women with pelvic organ prolapse. J Sex Med 2009; 6: 2286-2291
  • 38 Watanabe T, Rivas DA, Smith R et al. The effect of urinary tract reconstruction on neurologically impaired women previously treated with an indwelling urethral catheter. J Urol 1996; 156: 1926-1928
  • 39 McMurray G, Casey JH, Naylor AM. Animal models in urological disease and sexual dysfunction. Br J Pharmacol 2006; 147 (Suppl. 02) S62-S79
  • 40 Penson RT, Gallagher J, Gioiella ME et al. Sexuality and cancer: conversation comfort zone. The Oncologist 2000; 5: 336-344
  • 41 Sobecki JN, Curlin FA, Rasinski KA et al. What We Don’t Talk about When We Don’t Talk about Sex: Results of a National Survey of US Obstetrician/Gynecologists. Journal of sexual medicine 2012; 9: 1285-1294
  • 42 Hinchliff S, Gott M. Seeking medical help for sexual concerns in mid-and later life: a review of the literature. Journal of sex research 2011; 48: 106-117
  • 43 Farrell J, Belza B. Are older patients comfortable discussing sexual health with nurses?. Nursing research 2012; 61: 51-57
  • 44 Dyer K, das Nair R. Why don't healthcare professionals talk about sex? A systematic review of recent qualitative studies conducted in the United Kingdom. J Sex Med 2013; 10: 2658-2670